Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2018 Nov 1:13:3625-3634.
doi: 10.2147/COPD.S169951. eCollection 2018.

Improvement in hypercapnia does not predict survival in COPD patients on chronic noninvasive ventilation

Affiliations
Observational Study

Improvement in hypercapnia does not predict survival in COPD patients on chronic noninvasive ventilation

Tim Raveling et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Purpose: It has recently been shown that chronic noninvasive ventilation (NIV) improves a number of outcomes including survival, in patients with stable hypercapnic COPD. However, the mechanisms responsible for these improved outcomes are still unknown. The aim of the present study was to identify parameters associated with: 1) an improved arterial partial pressure of carbon dioxide (PaCO2) and 2) survival, in a cohort of hypercapnic COPD patients treated with chronic NIV.

Patients and methods: Data from 240 COPD patients treated with chronic NIV were analyzed. Predictors for the change in PaCO2 and survival were investigated using multivariate linear and Cox regression models, respectively.

Results: A higher level of bicarbonate before NIV initiation, the use of higher inspiratory ventilator pressures, the presence of anxiety symptoms, and NIV initiated following an exacerbation compared to NIV initiated in stable disease were associated with a larger reduction in PaCO2. A higher body mass index, a higher FEV1, a lower bicarbonate before NIV initiation, and younger age and NIV initiation in stable condition were independently associated with better survival. The change in PaCO2 was not associated with survival, neither in a subgroup of patients with a PaCO2 >7.0 kPa before the initiation of NIV.

Conclusion: Patients with anxiety symptoms and a high bicarbonate level at NIV initiation are potentially good responders in terms of an improvement in hypercapnia. Also, higher inspiratory ventilator pressures are associated with a larger reduction in PaCO2. However, the improvement in hypercapnia does not seem to be associated with an improved survival and emphasizes the need to look beyond PaCO2 when considering NIV initiation.

Keywords: bicarbonate; carbon dioxide; chronic obstructive pulmonary disease; exacerbation; home mechanical ventilation; respiratory insufficiency.

PubMed Disclaimer

Conflict of interest statement

Disclosure PJW reports grants and personal fees from Philips Respironics, RESMED, and VIVISOL, and grants from MediqTefa and Air Liquide, outside the submitted work. MD reports grants and personal fees from Philips Respironics, grants from RESMED Ltd, and Breas Medical, and personal fees from Vivisol BV, outside the submitted work. Funding sources had no involvement in the study design and in the collection, analysis, and interpretation of data. The other authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Flowchart of the study. Note: aDiscontinued NIV due to lung transplantation, lung volume reduction therapy, or recovery of respiratory failure. Abbreviations: NIV, noninvasive ventilation; ARF, acute respiratory failure.
Figure 2
Figure 2
Survival curves of patients initiated on NIV. (A) Patients initiated on NIV in stable condition and after a COPD exacerbation, corrected for the remaining predictors. (B) Survival curves referring to the percentage of change in PaCO2 after 12 months for a subgroup of patient (n=69) with baseline PaCO2 >7.0 kPa. Abbreviations: ARF, acute respiratory failure; NIV, noninvasive ventilation; PaCO2, arterial carbon dioxide pressure.

References

    1. Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188–207. - PubMed
    1. Mannino DM. Epidemiology and global impact of chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2005;26(2):204–210. - PubMed
    1. Dreher M, Storre JH, Schmoor C, Windisch W. High-intensity versus low-intensity non-invasive ventilation in patients with stable hypercapnic COPD: a randomised crossover trial. Thorax. 2010;65(4):303–308. - PubMed
    1. Duiverman ML, Wempe JB, Bladder G, et al. Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir Res. 2011;12:112–9921. - PMC - PubMed
    1. Windisch W, Storre JH, Köhnlein T. Nocturnal non-invasive positive pressure ventilation for COPD. Expert Rev Respir Med. 2015;9(3):295–308. - PubMed

Publication types

MeSH terms